GlassScriptPhysician profile
Thomas J Ruane
NPI 1730189218
$2,819.48
in general payments reported to CMS, 2019-2025
34 companies · $272 in 2025
The $272 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $176 · 2021: $114 · 2022: $667 · 2023: $799 · 2024: $643 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,678 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,677.88 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $293.74 | 2022-2025 | Erleada |
| Coloplast Corp | $267.35 | 2022-2025 | Speedicath |
| Karl Storz Endoscopy-America | $265.03 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $225.61 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $219.86 | 2019-2025 | Spaceoar Vue System - 10ml |
| Abbvie INC. | $205.63 | 2022-2024 | Botox |
| Merck Sharp & Dohme LLC | $161.30 | 2019-2024 | Lynparza, Keytruda, Welireg |
| Myriad Genetic Laboratories, INC. | $124.32 | 2023-2024 | Prolaris |
| Procept Biorobotics Corporation | $80.51 | 2024-2025 | Aquabeam System |
| Hollister Incorporated | $77.38 | 2022-2023 | Infyna Chic, Vapro |
| 180 Medical, INC. | $72.66 | 2022-2024 | Gentlecath |
| Rochester Medical Corporation | $70.55 | 2020-2022 | |
| Urogen Pharma, INC. | $70.17 | 2023-2024 | Jelmyto |
| Endo Pharmaceuticals INC. | $63.62 | 2022 | |
| Halozyme INC | $51.13 | 2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $48.96 | 2022 | |
| Tolmar, INC. | $44.54 | 2023 | |
| Dendreon Pharmaceuticals LLC | $42.21 | 2022 | |
| Urovant Sciences INC | $40.56 | 2022 | |
| Pfizer INC. | $36.50 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Laborie Medical Technologies Corp. | $33.78 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Astellas Pharma US INC | $33.53 | 2020-2024 | Xtandi |
| Antares Pharma, INC. | $33.51 | 2024 | Xyosted |
| C. R. Bard, INC. & Subsidiaries | $30.02 | 2023-2024 | Bard Inlay Optima Ureteral Stent With Hydroglide Guidewire |
| Baxter Healthcare | $29.28 | 2024 | Perclot |
| Myovant Sciences INC. | $29.24 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.09 | 2024 | |
| Convatec INC. | $21.08 | 2023 | |
| Axonics, INC. | $19.11 | 2023 | Bulkamid |
| Immunitybio, INC. | $19.02 | 2024 | |
| Allergan, INC. | $18.15 | 2022 | |
| Endo USA, INC. | $17.53 | 2024 | Aveed, Edex, Xiaflex |
| Photocure INC | $15.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Ruane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.